Search Results - "Karakaya, Bülent"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    A patient presenting with ARDS after COVID-19 vaccination: A COVID-19 case report by Sahin Tutak, Ayse, Söylemez, Fatih, Konuk, Hazal B., Çakmak, Erkan, Karakaya, Bülent, Doğan, Ali, Sayiner, Hakan S., Aksöz, Selçuk, Alev, Mehtap

    Published in Journal of infection and public health (01-10-2021)
    “…•SARS-CoV-2 IgG and IgM-A levels should be measured at baseline and repeated on days 6–8 of treatment in patients with negative COVID-19 PCR test…”
    Get full text
    Journal Article
  2. 2

    Investigation of benfotiamine’s protective effects on liver tissue in experimental carbon tetrachloride induced liver injury by Karakaya,Bülent, Kuloğlu,Tuncay, Önalan,Erhan, Kaya Tektemur,Nalan, Dönder,Emir

    Published in Cukurova Medical Journal (30-06-2020)
    “…Purpose: In this study, we aimed to investigate the protective effects of benfotiamine on experimental liver injury caused by carbon tetrachloride (CCl4)…”
    Get full text
    Journal Article
  3. 3

    QT dispersion and P wave dispersion in patients with fibromyalgia by Yolbaş, Servet, Yıldırım, Ahmet, Düzenci, Deccane, Karakaya, Bülent, Dağlı, Mustafa Necati, Koca, Süleyman Serdar

    Published in European journal of rheumatology (01-12-2016)
    “…Fibromyalgia (FM) is a chronic disease characterized by widespread pain. Somatic complaints associated with the cardiovascular system, such as chest pain and…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Karbon tetraklorür ile oluşturulan deneysel karaciğer hasarında benfotiamin’in karaciğer dokusu üzerine koruyucu etkilerinin incelenmesi by Bülent Karakaya, Tuncay Kuloğlu, Erhan Önalan, Nalan Kaya Tektemur, Emir Dönder

    Published in Cukurova Medical Journal (01-06-2020)
    “…Amaç: Bu çalışmada karbon tetraklorür (CCl4) ile oluşturulan deneysel karaciğer hasarında benfotiaminin karaciğer dokusu üzerine koruyucu etkilerinin…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Change in plasma a disintegrin and metalloprotease with thrombospondin type-1 repeats-13 and von Willebrand factor levels in venous thromboembolic patients by Karakaya, Bulent, Tombak, Anil, Serin, Mehmet Sami, Tiftik, Naci

    Published in Hematology (Luxembourg) (27-05-2016)
    “…Venous thromboembolism (VTE) is an important cause of morbidity and mortality. A disintegrin and metalloprotease with thrombospondin type-1 repeats-13…”
    Get more information
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14